EORTC QLQ-BR23
EORTC Quality of Life Questionnaire – Breast Cancer Module (QLQ-BR23)
A breast cancer-specific quality-of-life module used alongside the core EORTC QLQ-C30 cancer questionnaire.
At a Glance
- Population
- Adults with breast cancer
- Number of Items
- 23 items
- Instrument Type
- PROM
- Digital Administration Availability
- Suitable for self-report electronic administration
- Automated Scoring Availability
- Yes — EORTC scoring manual defines standardised subscale transformations
- Suitable Use Settings
- Oncology clinical care and cancer clinical trials
About the Instrument
Developed by the EORTC Quality of Life Group, the QLQ-BR23 is a disease-specific supplement used together with the core EORTC QLQ-C30 questionnaire in breast cancer research and care. It has since been updated by the group as the QLQ-BR45.
What It Measures
Breast cancer-specific quality-of-life domains including body image, sexual functioning, arm and breast symptoms, and treatment side effects, alongside functional and symptom scales.
Digital Administration
Delivered electronically through the PROMinsight platform as part of a digital patient-reported outcomes workflow.
Scoring / Reporting
Scored per the EORTC QLQ-C30/BR23 scoring manual, producing multiple function and symptom subscale scores on a 0–100 scale.
Use in Research / Clinical Care / Clinical Trials
A core patient-reported outcome measure in international breast cancer clinical trials, typically paired with the EORTC QLQ-C30.
Enquire About This Instrument
Interested in using the EORTC QLQ-BR23 in your research, clinical programme or study? Contact PROMinsight to discuss access.
Enquire About This Instrument